GMP Companies, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Series of private placements totaling $28.2 mil. will facilitate commercialization and development of the firm's products, including the ThromboFlex blood coagulation monitor and an anti-embolism stocking to prevent deep-vein blood clots in hospitalized patients. The financing includes a $9.5 mil. investment by Medtronic. Quest Diagnostics contributed $7.1 mil. Other investors were Motorola, Texas Pacific Group, and J&W Seligman & Co. The Fort Lauderdale-based firm has raised a total of $134 mil. since its founding in May 1999